Delayed sentinel lymph node biopsy safe after melanoma diagnosis

Postponement of sentinel lymph node biopsy more than 30 days after melanoma diagnosis did not have a negative effect on long-term survival, according to study results.

Going to the Wall Against Cancer and Apathy

Source: Fortune, July 2017 When I emailed ANZ Bank’s group executive Mark Whelan about a volleying challenge against cancer, he was on vacation but immediately looped in his heads of marketing and social media. They arranged for their ambassadors Rod Laver and Martina Navratilova to make volleying videos. Rod didn’t hesitate, even though he’s in […]

Young Women Are the Fastest Growing Demographic for Getting Skin Cancer: Important Summer Tips For Women

Source: Long Beach Post, July 2017 People Post is a space for opinion pieces, letters to the editor and guest submissions from members of the Long Beach community. The following is a guest post by Dr. Lindsay Larson, a primary care physician with OptumCare Medical Group, located in Long Beach. In Southern California we spend […]

Postoperative Radiotherapy for Malignant Melanoma: 10 Reasons to Renew Research in the Age of Immunotherapy

Source: ASCO Connection, July 2017 Immunotherapy shows promise not only in metastatic melanoma but also in curative treatment. Ipilimumab can help improve survival in stage III melanoma.1 Postoperative radiation may help build on immunotherapy’s success in several ways. Here are 10 reasons why we should look at postoperative radiation for regional disease. 1. Radiation can damage […]

Cancer in the News

Feature Articles

Could Tomatoes Fight Against Skin Cancer?

Nutrient rich tomatoes may be an effective tool in fighting skin cancer. In a mouse study, researchers from The Ohio State University found that daily tomato consumption cut the development of non-melanoma skin cancers in half.

Read the full story

Posted in Melanoma In The News, Information

CheckMate 037: Nivolumab Improved Responses, Not Survival in Advanced Melanoma

Patients with advanced melanoma treated with nivolumab had higher and more durable responses compared with investigator’s choice of chemotherapy, but these increases did not result in improved survival outcomes, according to the results of the CheckMate 037 study published in the Journal of Clinical Oncology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Pembrolizumab Plus Reduced-dose Ipilimumab Safe in Advanced Melanoma

Patients with advanced melanoma may have good outcomes when treated with standard-dose pembrolizumab with 4 doses of reduced-dose ipilimumab, according to a study published in The Lancet Oncology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Medicare, insurance beneficiaries have improved access to uveal melanoma test

Three important access milestones for DecisionDx-UM have been reached, Castle Biosciences announced in a press release.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories